Step 1 topics → Immunology → HIV Immunology

HIV Immunology

USMLE Step 1 trap: Overlooks the obligatory co-receptor (CCR5 or CXCR4) required for HIV cell entry alongside CD4. HIV requires CD4 as the primary receptor plus a co-receptor—CCR5 for macrophage-tropic (R5) strains early in infection, and CXCR4 for T cell-tropic (X4) strains in late disease.

HIV immunology is one of the most consistently tested topics on USMLE Step 1, and for good reason — it connects virology, cell biology, and clinical medicine in one tight package. At its core, you need to understand how HIV enters cells (receptors and co-receptors), how CD4 T cell depletion creates predictable clinical vulnerabilities, and how to use CD4 count thresholds to reason through which opportunistic infections (OIs) are on the table. The exam tests this at every level: pure recall (which co-receptor does R5 HIV use?), clinical application (what prophylaxis does this patient need?), and passage-based reasoning (interpreting a novel mutation in CCR5 and predicting what happens).

What trips students up most is oversimplifying HIV entry — thinking CD4 alone is sufficient for viral entry, or thinking that CCR5-delta32 protects against every HIV strain. Neither is true, and the USMLE Step 1 will absolutely probe both. The other high-yield trap is treating all AIDS-defining OIs as if they share a single CD4 threshold. They don't — the thresholds are staggered and the exam tests whether you know the specific cutoffs for PCP, MAC, CMV, and others.

Finally, mucocutaneous Candida is a classic differential diagnosis anchor on USMLE Step 1. Students frequently misattribute oral thrush in an adult to a phagocyte defect. The correct mental model is that T cells suppress mucosal Candida; when T cells fail (like in HIV), you get mucocutaneous disease. Phagocyte defects cause invasive, disseminated Candida — a completely different presentation. Get these patterns locked in and you'll handle any HIV immunology question the exam throws at you.

From real student decks
38%have cards covering this topic
22%have mature cards

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: HIV uses only CD4 to enter cells.
Right: HIV requires CD4 as the primary receptor plus a co-receptor—CCR5 for macrophage-tropic (R5) strains early in infection, and CXCR4 for T cell-tropic (X4) strains in late disease.
CD4 binding is necessary but not sufficient for HIV entry — it only causes a conformational change in gp120 that exposes the co-receptor binding site. Without co-receptor engagement (CCR5 or CXCR4), gp41 cannot drive membrane fusion and the virus cannot enter. This two-step requirement is why drugs like maraviroc (a CCR5 antagonist) can block infection even though CD4 is still present and unaffected.
Common mistake
Wrong: CCR5-delta32 homozygotes are immune to all HIV strains.
Right: CCR5-delta32 homozygotes are resistant to R5 (CCR5-tropic) HIV strains but remain susceptible to X4 (CXCR4-tropic) strains, though X4 strains rarely initiate infection.
CCR5-delta32 homozygosity eliminates surface CCR5 expression, which blocks entry of R5-tropic strains — the strains that almost exclusively initiate new infections. However, X4-tropic strains use CXCR4 instead, so delta32 homozygotes are not protected against them. The reason delta32 homozygotes are effectively resistant in practice is that X4 strains rarely transmit efficiently; they typically emerge later from R5 strains in established infection. Don't overgeneralize this protection.
Common mistake
Wrong: All AIDS-defining opportunistic infections occur at the same CD4 threshold.
Right: OI prophylaxis thresholds are staggered: PCP and Toxoplasma at <200, MAC at <50, and CMV retinitis at <50, while Candida esophagitis and Cryptococcus occur around 100–200.
The staggered CD4 thresholds aren't arbitrary — each pathogen has a different virulence and requires a specific degree of immune suppression to cause disease. PCP (Pneumocystis) and Toxoplasma become threats at <200 because they require robust T cell surveillance to stay dormant. MAC and CMV are more opportunistic and only take hold when immunity is devastated at <50. Knowing the specific cutoffs lets you determine both which OIs are on the differential and which prophylaxis regimens are indicated.
Common mistake
Wrong: Oropharyngeal Candida in an adult always indicates a phagocyte defect.
Right: Mucocutaneous Candida (oral thrush, esophagitis) in an adult without neutropenia indicates a T cell defect (e.g., HIV), because intact T cells normally suppress Candida; invasive Candida in a neutropenic patient indicates a phagocyte defect.
T cells — specifically Th17 cells — are the primary defenders against mucosal Candida overgrowth. When T cells are depleted (as in HIV), Candida colonizes mucous membranes causing thrush and esophagitis without ever becoming invasive. Neutrophils (the phagocytes) are what kill Candida if it enters the bloodstream or tissue, so phagocyte defects (like neutropenia or CGD) lead to invasive, disseminated candidiasis — not mucocutaneous. If you see oral thrush in an adult with an intact neutrophil count, think T cell defect first.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the full HIV entry sequence: gp120 binds CD4 first, then requires a co-receptor — CCR5 (for macrophage-tropic R5 strains, dominant early in infection) or CXCR4 (for T cell-tropic X4 strains, emerging in late disease) — before gp41 mediates membrane fusion.
  2. Understand the CCR5-delta32 mutation: homozygotes are highly resistant to R5-tropic HIV (the strain that typically initiates infection) and this is the basis for the CCR5 antagonist maraviroc, but delta32 homozygotes retain susceptibility to X4-tropic strains.
  3. Memorize staggered CD4 count thresholds for AIDS-defining opportunistic infections: PCP and Toxoplasma prophylaxis at <200, Cryptococcus and Candida esophagitis around 100–200, and MAC plus CMV retinitis at <50.
  4. Use the Candida pattern to distinguish T cell from phagocyte defects: mucocutaneous Candida (thrush, esophagitis) in a non-neutropenic adult points to T cell deficiency (HIV being the classic cause), while invasive/disseminated Candida in a neutropenic patient points to a phagocyte defect.

Can you avoid these mistakes?

A patient with HIV is found to have an R5-tropic virus on genotyping. His provider considers adding maraviroc to his regimen. What exactly does maraviroc block, and why would it be ineffective if the patient's virus switched to an X4-tropic strain?
A 34-year-old man is newly diagnosed with HIV and has a CD4 count of 160 cells/µL. Which opportunistic infection prophylaxis regimens are indicated at this CD4 level, and which ones are not yet needed?
A 28-year-old woman with no history of neutropenia develops painful swallowing and is found to have white plaques in her oropharynx and esophagus on endoscopy. What immune defect does this pattern suggest, and how would the presentation differ if she had a phagocyte defect instead?
A researcher discovers a patient who is homozygous for CCR5-delta32 and has been repeatedly exposed to HIV through high-risk behavior but remains uninfected. A colleague claims this patient is immune to all HIV. What is the flaw in that claim, and under what theoretical circumstance could this patient still acquire HIV?

Related topics

T Helper Subsets and Treg Thymus and T Cell Maturation Spleen Architecture and Function Lymph Node and MALT Architecture Innate Immune Cells Overview

See how your Anki deck covers this topic.

Upload your deck for a free audit →